Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences
Session On: Insight of Stem cell
Stem celldiffer according to their source and their malleability: Early or embryonic andmature or adult stem cellhold a great therapeutic potential. The first documentation of isolation ofearly stemcell was done in 1994 in Human blastocysts which leads to the evolution ofembryonic stem cellculture and techniques and substantially improved. Whereas the mature stem cellare witnessed in specific mature body tissueslike neural stem cell,skin cells, Hematopoietic stem cell,umbilical cordblood and placenta after birth.
Related: Stemcells Conference | Stemcell Conferences | Regenerativemedicine Events | TissueEngineering Meetings | TissueScience Summit | CancerWorkshops | CellsScience Congress | BiomarkersSymposium
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
InternationalSociety for stem cell research; Australian Society for StemCell Research; InternationalSociety of Differentiation; New York Stem CellFoundation; AmericanAssociation of Stem Cell Physicians
Session On: Stem cellTreatments and Therapies
Recent research is underway to develop to noveltechnologies, various sources to apply stem celltreatments for disorders and diseases includes neurological, cardiology, ortho,dental, dermatology, diabetes, Cancerand so on. Cumulative results of this research show, the stem celltreatment patients improved their symptoms by an average of 81.6% and 72% ofthese improvements occurred immediately. Ongoing examination were showingstatistically huge improvements in patients at numerous measures: ExpandedDisability Status Scale (EDSS) score, Neurologic Rating Scale (NRS), MultipleSclerosis Functional Composite (MSFC), personal satisfaction, and injury volume.Perhaps the most compelling statistic is that progression-free survival was 87%for patients at the four-year point.
Related: Stemcells Conferences | Stemcell Events | Regenerativemedicine Meetings | TissueEngineering Summit | TissueScience Workshops | CancerCongress | CellsScience Symposium | BiomarkersConference
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Session On: Stem cellCulture and Bioprocess
Stem cellculture can be done in vivo and in vitro, since suboptimal media may change thedifferentiation potential of stem cell,it is important to select the specific stem cellvalidated media and reagents at the start of your research process. Recently, cellsculture protocols, such as organoid cellscultures, have provided more predictive in vitro cellular “Disease-in-a-Dish”models. The development of bioprocess technologies to achieve control,reproducibility, automation, validation and safety of the process and theproduct and Envisages the use of stem cellin regenerativemedicine and drug screening applications. New technology has been provedthat, one square meter would produce enough cells to treat 4,000 patients,while traditional methods would require less than this.
Related: Stemcells Events | Stemcell Meetings | Regenerativemedicine Summit | TissueEngineering Workshops | TissueScience Congress | CancerSymposium | CellsScience Conference | BiomarkersConferences
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
EuropeanConsortium for Stem Cell Research; International Society forStem Cell Research; Stem CellSociety Singapore; TaiwanSociety for Stem Cell Research; TheAmerican Society of Gene & Cell Therapy
Session On: Stem celltransplantation
A total of 1 million stem celltransplants have been performed worldwide. Today, more than 70 cancerand non-Cancerous diseases are typically treated with a stem celltransplant. Survival rates have increased significantly among patients whoreceived blood stem celltransplants from both related and unrelated donors. Recent research done on38,000 patients who are affected with serious blood cancerand diseases over a 12-year period shows the significant improvement in theirsurvival rates from 48- 63 percent. For a long time, stem celltransplant activity was limited to patients with coordinated familycontributors (range of 30% of the patients), random donor registries will bevery less (i.e.) 1 out 500.000. At present, cordblood has been utilized as an alternate of donor and achieved more than2000 Cordblood Haematopoietic Stem CellTransplants yearly.
Related: Stemcells Meetings | Stemcell Summit | Regenerativemedicine Workshops | TissueEngineering Congress | TissueScience Symposium | CancerConference | CellsScience Conferences | BiomarkersEvents
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Session On: CancerStem cell and therapeutics
Emerging evidence suggested that cancerand stemcell might play an important role in resistance to traditional cancertherapies, and the studies of cancerstem cell especially castration resistant disease. Worldwide market size ofthe cancerstem cell has been USD 679.5 million in 2016 and expanded to CAGR of 9.98%at consecutive periods. Though cancerfield has conventional therapies including chemo, radiation and surgery, stem cellplays a great role in cancertreatment and therapy. Having huge challenges in regulation and ethical issues,stemcell research is growing enormously around the world.
Related: Stemcells Summit | Stemcell Workshops | Regenerativemedicine Congress | TissueEngineering Symposium| TissueScience Conference | CancerConferences | CellsScience Events | BiomarkersMeetings
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
NationalAssociation of Stem Cell Therapists; American Association ofStem Cell Physicians; AmericanAssociation for Cancer Research; American Society ofClinical Oncology; EuropeanOrganisation for Research and Treatment of Cancer
Session On: CellPlasticity and Reprogramming
Stem cellplasticity is the ability of adult tissue-specific stem cellto switch to new identities. Many laboratories have given evidence on stem cellplasticity; however, there is a controversy among the scientists have not foundthe data persuasive and have remained skeptical about these new findings. Someexamples of plasticity where differentiated cellsor their precursors can be reprogrammed by extracellular tissueto alter their character in ways that could have important implications for cellstherapy and other forms of regenerativemedicine. The mesenchymal stem cellhave a greater plasticity than others and can contribute to a range ofdifferent tissue.
Related: Stemcells Workshops | Stemcell Congress | Regenerativemedicine Symposium | TissueEngineering Conference | TissueScience Conferences | CancerEvents | CellsScience Meetings | BiomarkersSummit
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
TheAmerican Society of Gene & Cell Therapy; International Society ofDifferentiation; NationalNetwork of Cell Therapy; Tissue and Cell EngineeringSociety; TissueEngineering and Regenerative Medicine International Society
Session On: ArtificialOrgans & OrganRepair
In 1885, Von Frey and Gruber were the first to make andutilize an artificial organ,a heart-lung device. Today, there is much proof proposing that organ- specific stem cell.However, the greatest accomplishment was first detailed in 2006 whenspecialists done artificial urinary bladders in a lab and transplanted theminto patients. The future patterns of bio-designed and 3D printed organindicate open doors for development in relatively every angle. 3D bioprinting,is the emerging technique in the field of medicine which is quite remarkable.For over 10 years researchers have been persuaded that undifferentiated cellswere the eventual fate of organrepair since they can turn out to be any cellsin the body, reversing harm which was believed to be changeless.
Related: Stemcells Congress | Stemcell Symposium | Regenerativemedicine Conference | TissueEngineering Conferences | TissueScience Events | CancerMeetings | CellsScience Summit | BiomarkersWorkshops
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
TaiwanSociety for Stem Cell Research; Stem Cell Society Singapore;Australia:Organ and Tissue Authority; The Canadian Association ofTransplantation Canadian Blood Services: Organ andTissue Donation and Transplantation
Session On: Biomaterials& Scaffolds
In 2006, Chung pioneered the principal whole organtransplant utilizing adult stem celland a scaffold for clinical assessment. Meanwhile, the world scaffold elementtechnology market was approximately 4.57 million dollars in 2013, and byincreasing 13.4% annually, it is estimated to expand to 10.63 million dollarsby 2020. Numerous scaffolds produced from a variety of biomaterialsand manufactured using a plethora of fabrication techniques which has a keyconsideration like biocompatibility, biodegradability, mechanical properties,scaffold architecture and manufacturing technologies in the field of stem cell.
Related: Stemcells Symposium | Stemcell Conference | Regenerativemedicine Conferences | Tissue Engineering Events| TissueScience Meetings | CancerSummit | CellsScience Workshops | BiomarkersCongress
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related associations:
InternationalSociety of Biomedical Polymers and Polymeric Biomaterials; UK Society for Biomaterials;InternationalSociety for Stem Cell Research; Japanese Society forBiomaterials; ChineseSociety for Biomaterials
Session on: Microarrays& Biomarkers
Microarrays have reformed molecular biology to perform worldwideanalysis on the statement of a huge number of qualities at the same time Theyhave been generally utilized as a part of gene discovery, biomarkersassurance, disease classification, and investigations of gene regulation.Microarrays have been applied in stem cellresearch to recognize the expression signatures and portray theirdifferentiation programs toward specific lineages. As of late, biomarkershave assumed an inexorably imperative part in drug development, understandingthe mechanism of a drug, researching efficacy and toxicity signals.Practically, it is basic in biomarkersresearch to hold fast to statistical principles and take after a soundmeasurable approach to limit bias and maximize precision.
Related: Stem cells Conference| Stem cell Conferences| Regenerative medicine Events| Tissue Engineering Meetings| Tissue Science Summit| Cancer Workshops| Cells Science Congress| Biomarkers Symposium
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
TheAmerican Society of Gene & Cell Therapy; Chinese Society for CellBiology; AmericanSociety of Clinical Oncology; International Society forStem Cell Research; InternationalSociety of Differentiation
Session On: Personalizedmedicine & DrugDiscovery
Different sources of stem cellincluding mesenchymal stem cell,embryonic stem celland induced pluripotent stem cell(iPSCs) have been considered in targeted therapies which numerous focus points.iPSCs as the novel and individual pluripotent stem cellhave been presented as the suitable contender for personalized cell therapies.A recent publication, report portrays, Emulate’s Intestine-Chip, that means topersonalize drug treatments for people experiencing from gastrointestinaldiseases like inflammatory bowel disease and Chrohn’s disease. An ongoing marketsector review on stem cellin research and drug discovery demonstrated that regardless of a lot of hypeand hope around stem cell,most drug discovery related endeavour’s today still fall into theclassification of fundamental research and the larger part towards theoncology/ Cancerterritory. Many new research tools are now obtainable which is expected tocatalyse a new target discovery in the stem cellresearch.
Related: Stem cells Conferences| Stem cell Events| Regenerative medicine Meetings| Tissue Engineering Summit| Tissue Science Workshops| Cancer Congress| Cells Science Symposium| Biomarkers Conference
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
EuropeanAssociation for Clinical Pharmacology; European Federation forPharmaceutical Sciences; TheAmerican Society of Gene & Cell Therapy; European BehaviouralPharmacology Society; SpanishSociety of Pharmaceutics and Pharmaceutical Technology
Session On: CellRejuvenation & RehabilitationEngineering
Aging is a risk factor for some conditions, for example,blood cancer.As we get mature, endothelial cellssupportive capacity decreases which leads to dysfunction. Today, more and morepeople are turning to stem celltherapy as the ultimate anti-aging treatment and recent research have indicatedthe possibility of rejuvenation of tissuestem cell through modulation of specific pathways plays an important rolein this phenomenon. In aging and canceradvancement processes, a pressure reaction termed “cellular senescence” may belinked to multiple pathogeneses of both degenerative and hyperplasticdiseases.
Related: Stem cells Events| Stem cell Meetings| Regenerative medicine Summit| Tissue Engineering Workshops| Tissue Science Congress| Cancer Symposium| Cells Science Conference| Biomarkers Conferences
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
IntestinalRehabilitation and Transplant Association; Brazilian Association forCell Therapy; NationalNetwork of Cell Therapy; California Institute forRegenerative medicine; InternationalSociety for stem cell research
Session On: Stem CellBio Banking & TissuePreservation
The biobanking market is required to achieve USD 2.69Billion by 2022 from USD 1.85 Billion of every 2017, at a CAGR of 7.8%.Advances in biobanking and the developing pattern of preserving cord blood stem cellof new-borns; government and private subsidizing to help regenerativemedication and the developing requirement for effective drug discovery andimprovement. Cord tissuebanking is of collecting, preparing and cryo-preserving the cord tissuefor future medical utilize. If the umbilical cord has 50 cms and Vita 34, the mesenchymalstemcell will be in large quantity when we are collecting in future.
Related: Stem cells Meetings| Stem cell Summit| Regenerative medicine Workshops| Tissue Engineering Congress| Tissue Science Symposium| Cancer Conference| Cells Science Conferences| Biomarkers Events
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
Stem CellSociety Singapore; Associationof stem cell banks of India; Americanassociation of tissue banks; European association oftissue banks; Tissueand Cell Engineering Society
Session On: Regenerativemedicine
Recently, the regenerativemedicine market is of $18.9 billion and will reach $53 billion by 2021. Theregenerativemedicine market has great scope and can be executed to a broad assortment ofdiseases and signs including neurological, immune system, cardiovascular,diabetes, musculoskeletal, visual, orthopaedic and wound healing. Universally,organizations dynamic in cellstreatments and other regenerativemedicine raised more than $6.1 billion in the initial seventy five percentof 2017. In future, there may be new pharmaceutical aggravates; those can enacttissuespecific stem cell,and elevate the stem cellto relocate to the side of tissuedamage, and elevate their separation to tissuespecific cells.
Related: Stem cells Summit| Stem cell Workshops| Regenerative medicine Congress| Tissue Engineering Symposium|Tissue Science Conference| Cancer Conferences| Cells Science Events| Biomarkers Meetings
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
NationalSociety of Regenerative Medicine; International Society ofRegenerative Medicine; TheJapanese Society for Regenerative Medicine; Canadian Association forResearch in Regenerative Medicine; AmericanAcademy and Board of Regenerative Medicine
Session On: Cellsand Tissue engineering
In recent years, a few examinations have utilized stem cellof various sources to reconstitute harmed tissue.The worldwide tissueengineering business sector estimated around USD 5 billion in 2016. Tissueengineering can have an alternate methods and solutions for transplants,surgical methods and mechanical devices. Use of nanotechnology is essential in tissueengineering procedure to think about cellscommunication at a solitary atom level. The applications are categorized asinto many divisions including Gynecology, neurology, cord blood, stem celletc. Most tissuesare not able to recover and consequently they repair.
Related: Stem cells Workshops| Stem cell Congress| Regenerative medicine Symposium| Tissue Engineering Conference| Tissue Science Conferences| Cancer Events | Cells Science Meetings| Biomarkers Summit
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
Internationalsociety for stem cell research; Tissue and Cell EngineeringSociety; RegenerativeMedicine Foundation; NationalNetwork of Cell Therapy; TheAmerican Society of Gene & Cell Therapy
Session On: NovelTechnologies in Stem Cells and Regenerative medicine
In 1960s, Stem cellhas been studied from adult, embryonic, mesenchymal and blood stem cellbut recently the treatment are implemented as bone marrow transplant. Stem cellresearch has extended its way to treat disease mechanism and clinical therapy.Since there is a disadvantage like immune rejection, regulation and ethicalissues, iPSCs holds a vital role in solving these issues. iPSCs is expected tobe a solution for many pharmaceutical development, drug delivery in the futurestudies.
Related: Stem cells Congress| Stem cell Symposium| Regenerative medicine Conference| Tissue Engineering Conferences| Tissue Science Events| Cancer Meetings| Cells Science Summit| Biomarkers Workshops
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
CaliforniaInstitute for Regenerative medicine; Israel Stem Cell Society;TissueEngineering and Regenerative Medicine International Society; National Association ofStem Cell Therapists; EuropeanConsortium for Stem Cell Research
Session On: Applicationof Stem cells in different fields
Human Stem cellcan be used in various fields like in the production of cellsfor cell-based therapies, to replace damaged cellsin the body of various condition including diseases and disorders. Manyprofessionals and scientists believe that stem celllike Vita 34, will be the best option for many therapeutics and Umbilical cordblood plays a major source for stem celland it holds positive encouragement for future medicine.
Related: Stem cells Symposium| Stem cell Conference| Regenerative medicine Conferences| Tissue Engineering Events| Tissue Science Meetings| Cancer Summit | Cells Science Workshops| Biomarkers Congress
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
New YorkStem Cell Foundation; Frenchsociety for stem cell Research; Danishstem cell society; Pakistanstem cell society; RegenerativeMedicine Foundation
Session On: ComputationalStem Cells Biology & SystemsBiology
Recently, the computational biology has been translated inboth knowledge and development basis. At cellular level, the stem celland regenerativemedicine are able to study but for molecular level there is a need ofmodern technologies to handle the data and thousands of gene products. Whereasbioinformatics in used in the field of stem celland regenerativemedicine.
Related: Stemcells Conference | Stemcell Conferences | Regenerativemedicine Events | TissueEngineering Meetings | TissueScience Summit | CancerWorkshops | CellsScience Congress | BiomarkersSymposium
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
NationalStem Cell Foundation; ChineseSociety for Cell Biology; BritishSociety for Cell Biology; American Society for CellBiology; TaiwanSociety for Stem Cell Research
Session On: Stem cellsproducts and Commercialization
The feasible outcomes emerging from stem cellhave brought great business enthusiasm, with potential applications including cellstreatment, tissueengineering, pharmacological testing on cell-specific tissue,toxicology screening, 3D printing etc. This tradition presents businessopenings and challenges in every aspect of stem celland regenerativemedicine explores including the applications, regulations, production,product development, funding, and the marketing of Stem Celland RegenerativeMedicine.
Related: Stemcells Conferences | Stemcell Events | Regenerativemedicine Meetings | TissueEngineering Summit | TissueScience Workshops | CancerCongress | CellsScience Symposium | BiomarkersConference
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
TheInternational Council of Biotechnology Associations; Medical TechnologyAssociation of India; Associationof Indian Medical Device Industry; California Association ofMedical Product; AustralianSociety for Stem Cell Research
Session On: Stem cell:Challenges and Ethicalissues
Stem cellexplore offers incredible guarantee for understanding and in addition thedesire for new therapies for various disorders and diseases. Even though, humanStemcell (hSC) research additionally raises moral and political discussions.Moral and social issues emerge to some degree at whenever the result affectsthe patients. There are obvious rules about morals accessible at US NIHguidelines on research on human embryonic stem cell.Commonly, this discussion targeted around embryonic stem cellthough less discussion were related to the cellsfrom the umbilical line, breast milk, bone marrow, which are not pluripotent.
Related: Stemcells Events | Stemcell Meetings | Regenerativemedicine Summit | TissueEngineering Workshops | TissueScience Congress | CancerSymposium | CellsScience Conference | BiomarkersConferences
Related Conference:
International Conferenceon Tissue science and Regenerativemedicine, Nov 19- 20, Paris, France; Translationalof stem cells to the clinic: Challenges and Opportunities,Dec 2- 4, 2018, Los angles, USA; Stemcells & Organoidsin Development & Disease,Feb 20- 22, 2019, Amsterdam, Netherlands; 2nd International Conferenceon Wound Care, TissueRepair and RegenerativeMedicine, February 21-22, 2019, Paris, France; International Conferenceon Biomarkers, March 11- 12, 2019, London, UK; 2nd International Conferenceon Stem cells and Regenerativemedicine, March 14- 15, 2019, London, UK; International Conferenceon Tissue engineering and Regenerative medicine,March 14-15, London, UK
Related Associations:
AmericanEthical Union; Ethical,Legal and Psychosocial Aspects of Organ Transplantation; NationalEthics Association; AmericanAcademy and Board of Regenerative Medicine; EuropeanFederation for Pharmaceutical Sciences
Future Market Scope:
The global market size of stem cell is valued $1,986 million in 2016 and expected to be $6,956 million by 2023 and of CAGR 15% during the period of 2018- 2023. Whereas the europe market is valued $ 2010 million in 2016 and expected to be $4540 million by 2023 and of CAGR 9.38% during the period of 2018- 2023.
The statistics shows the market size of various region with respective to years. It is estimated that the market has been elevated from 3.8 billion US dollars to 6.6 billion dollars from 2011 to 2016
The market size of stem cell for various regions around the Europe with respective to years.
Regenerative medicine:
The regenerative medicine shows the market size of $17.03 billion revenue in 2016 and is expected to be $50.55 billion by 2025. The north America shows the highest regenerative medicine globally and the overall global rate is expected to be 25.4% growth from 2016 to 2022.
Stem Cell banking:
Stem cell have some good therapeutics as well as biotechnological effects and they also used for replacing damaged and even to deliver the proteins by using cells specific stem cell. Past 10 years, umbilical cord blood played a very vital role in rescuing patients from inborn errors and it has greater advantage since they not depend on the human leukocyte antigen, graft rejection is less in number.
The umbilical cord blood transplant was first experimented in a five-year-old kid who was suffered from Fanconi anemia has been cured by allogeneic HSCT. Recently, umbilical cord blood is the major stem cell source where 2000 Cord blood stem cell transplants are done annually. In this year, about 35,000 patients umbilical cord blood has been received in the world and India which has a birth rate of 26 million births/ year shows the largest collector of umbilical cord blood in the world.
Now a day, public umbilical cord blood banks are growing vastly for the potential clinical use, where today it reached around 142 public banks and 25 private banks which are actively involved in sample collecting, preserving and testing for future use in the field of stem cell and therapeutics.
The very first operations have been achieved with ISO 13485 and certified with GMP, GLP and GCP in the consecutive operations. Based on the cancer stages and severeness of the diseases, around 30,000units of blood stem cell are distributed all over the world to treat from children to adults. The more transplant has performed in US, where 5000 umbilicals cord blood transplants has been done in 2009.
Asian Countries patients are suffering to get a transplant, since they are more diverse in HLA types, which in turn have drop in 1 out of 10 people in Asian population. The HLA tissue type can be inherited from parents or siblings which will be having a match of 6/6 antigens 25% and 4/6 match 39%. History of family plays a vital role in life threatening diseases and disorders.
Cord blood are used in different categories like 28% for treating genetic disorders, anaemia and immune deficiency. And the survival percentage is 20% higher in children who received matched stem cell and 60% in adults.
Even though the stem cell research started with children, now a day it has been evolved to adult studies where mismatch at two or more HLA antigens happens and the transplant mortality rate have increased to 50% because of infections which lead to regimen toxicity.
Top Associations around the World:
International Society for stem cell research; Australian Society for Stem Cell Research; International Society of Differentiation; New York Stem Cell Foundation; European Consortium for Stem Cell Research; National Association of Stem Cell Therapists; National Stem Cell Foundation; Stem Cell Society Singapore; Taiwan Society for Stem Cell Research; The American Society of Gene & Cell Therapy; Tissue Engineering and Regenerative Medicine International Society; California Institute for Regenerative medicine
Universities Associated with Stem cell Research:
Universities in Worldwide:
National Institutes of Health; Minnesota stem cell institute; University of Stanford; Harvard University; University of Michigan; University of Southern California; Utrecht University
Universities in London:
University of Birmingham; The University of Edinburgh; The University of Sheffield; University of Leeds; University of Newcastle; University of Manchester; University of Nottingham; University of Cambridge; King's College London; Imperial College London; Queen Mary University of London; Middlesex University London; University of Liverpool
Top Hospitals in the world:
Heidelberg University Hospital; St. Catherine Specialty Hospital - Stem Cell; Darrow Stem Cell Institute; Stem Cell Transplant Institute ; StemCell21; The Melrose Aesthetic Centre; Allure Medical Spa (Stem Cell); Charm - Center for Healing and Regenerative Medicine
Top Hospitals in London:
London Bridge Hospital; Aspen Healthcare; UK Stem cell Hospital; Stem Cell Treatment UK; Spire Healthcare Group; Centre for Regenerative Medicine; Southampton general hospital; Whittington Hospital; University College Hospital; Cell and Gene Therapy Catapult; The London Clinic; King's College Hospital; Highgate Private Hospital; St Bartholomew's Hospital; Imperial Private Healthcare
Industries Associated with Stem cell Research:
MetriGenix; Sangamo Therapeutics; Athersys; Pluristem Therapeutics; Cellular Biomedicine Group; Vericel; BrainstormCell Therapeutics; Caladrius Biosciences; Cytori Therapeutics; Cesca Therapeutics; VistaGen Therapeutics; TiGenix; Cellerant Therapeutics; BioTime, Inc; inStem; Osiris Therapeutics; Neuralstem, Inc.; Cartherics Pty Ltd
DISCLAIMER
This report has been done only for the analyzation of the current research with respective venues. The information does not have any of the illegal or confidential data.
We gladly invite everyone from everywhere throughout the world to join the gathering of “2nd World Congress on Stem cells and Regenerative Medicine” during the days March 14- 15, 2019 at London, UK.
Stem cells congress covers the topics from sources, culture, treatments, therapies, transplantation, regeneration, personalized medicine and to its applications like cell plasticity, reprogramming, organ repair, artificial organ, banking and more.
Stem cell research can elevate its height by gathering all the researchers from worldwide who are directly linked with stem cell and regenerative medicine and its allied fields. This conference plays a Global platform for biomedical companies, start-ups, students, professionals, specialists, consultants, doctors and scholars to frame new relationship and strengthen the Knowledge.
Get a chance to reinvent your self and have fun with coffee breaks, lunch session. We open this opportunity to welcome all of you in London, UK and go along with us to have a great sharing of knowledge to lead the future with our logical minutes.
Our motto to organize this conference is to Integrate the Milestones to Improve the Stem cell and Regenerative Medicine to lead a future in better way.
We are very much excited to gather all the great and knowledge people at one place and we are warmly inviting everyone to join with us. Let’s meet in the London city to share our thoughts to have a better tomorrow.
Explore the evidence to make a difference!
Regards
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
